Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Update on quinolone-containing rescue therapies for Helicobacter pylori infection.

World journal of gastroenterology - 21 Apr 2020

Mori Hideki, Suzuki Hidekazu

Abstract excerpt

Third generation of quinolones, such as levofloxacin and moxifloxacin, -containing regimens are often used in second-line or rescue treatment of Helicobacter pylori infection. However, the increasing antibiotic resistance to quinolones affects the efficacies of quinolones-containing therapies in recent years. Therefore, there is a need to enhance the effectiveness of quinolones-containing therapies. Sitafloxacin,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Gyrase
Share to Evidence-Based Medicine
Share to Fluoroquinolones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Helicobacter Infections

Share to Helicobacter pylori

Share to Proton Pump Inhibitors

Share to Pyrroles

Share to Sulfonamides

Source

Open in PubMed Open full text

Identifiers

PMID: 32351290
DOI: 10.3748/wjg.v26.i15.1733
PMCID: PMC7183861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update on quinolone-containing rescue therapies for Helicobacter pylori infection.PMID 32351290Read ↗

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Semantic proximity Read ↗

Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection.Semantic proximity Read ↗

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Semantic proximity Read ↗

Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.Semantic proximity Read ↗

Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.Semantic proximity Read ↗

Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimensSemantic proximity Read ↗

Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeuticsSemantic proximity Read ↗

In vitro anti-Helicobacter pylori activity and phenotypic screening of novel quinolone compounds.Semantic proximity Read ↗

Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy.Semantic proximity Read ↗

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.Semantic proximity Read ↗

Treatment of Helicobacter pylori infection: Where are we now?Semantic proximity Read ↗

Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.